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My perspective is different from that of Dr. Weksler. 
I see age-related loss of responsiveness as a cardinal 
feature of immunosenescence, one that puts elderly 
people at risk of infection and perhaps neoplasia. It 
is possible that age-associated increases in the ac- 
tivity of some kinds of immune cells, which Dr. 
Weksler has emphasized, contribute to this decline 
in protective immunity, although this hypothesis 
needs a good deal of further investigation. I do not 
see autoimmunity as a major threat to the elderly or 
an important component of immunosenescence, al- 
though the jury is still out on this, and clearly in- 
vestigators of autoreactivity have the potential for 
teaching us a lot about how the aged immune sys- 
tem works. 
Thus in my view one of the most pressing chal- 
lenges for immunogerontologists is to figure out 
why the immune system generates fewer antibodies 
to specific antigens, fewer cytotoxic T cell effectors, 
and less protection against potential infections and 
pathologic agents in elderly humans and old mice. 
I will call this deficiency of function, and I think 
that some of the cross-wiring that Dr. Weksler and 
others have pointed out may give us a way of ex- 
ploring it anew. I am not convinced by arguments 
to date that have suggested an important patholog- 
ical implication for autoimmunity. Some autoim- 
mune phenomena are demonstrated in elderly mice 
and humans, but their pathological implications are 
still mysterious; more work needs to be done to 
understand the implications for health and disease. 
The cellular and molecular basis for the age- 
related decline in immune responsiveness can be 
enumerated in several ways. First, there is an age- 
related change in T cell subsets. Figure I shows that 
there is an age-associated accumulation of memory 
(Pgp-lhi) T'cells.  There is a decrease with age in 
the number of virgin T lymphocytes resulting in a 
relatively greater proportion of memory as com- 
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pared to virgin T cells. This result has been found 
in many laboratories in both mice and humans. 
When one uses CD44+, a marker of memory cells, 
one finds nearly triple the number of memory cells 
in the spleen, lymph nodes, or blood of old com- 
pared to young mice. 
Second, is this change in T cell subsets impor- 
tant and do these shifts contribute to the age-asso- 
ciated changes in cytokine production? Kevin Flur- 
key and his colleagues' use a limiting dilution, cell- 
counting assay. Figure 2 shows that T cells from 
young animals (about 55%) could make interleukin- 
2 (IL-2) when they were stimulated with concana- 
valin (Con) A. Virgin cells purified from the T cells 
can make IL-2 and IL-3. In this kind of assay the 
purified memory lymphocytes do not make IL-2 or 
IL-3, regardless of whether they are stimulated with 
Con A (Figure 2) or with staphylococcal enterotox- 
in (SEB, known to trigger the T cell receptor) (Fig- 
ure 3). Essentially all the responder cells in young 
and old mice are of the virgin type. The accumu- 
lation of this memory cell population accounts for 
the age-associated loss in the fraction of cells in an 
unsorted T cell population that can make IL-2 and 
In addition to measuring lymphokine produc- 
tion, we have looked at the ability of cells to re- 
spond to IL-2. Figure 4 shows results from a lim- 
iting dilution (LD) assay to identify the precursors 
of proliferating and cytotoxic T lymphocytes. There 
is an age-related loss in the number of both prolif- 
erating and cytotoxic T cell precursors. This is an 
IL-2 driven reaction, as shown in Figure 4. In young 
or old mice, naive cells respond .well while the 
memory cells do not respond as well. The age-as- 
sociated increase in this memory cell fraction large- 
ly accounts for the age-related loss in the number 
of cells that proliferate or generate cytotoxic effec- 
tors in this IL-2-driven reaction. A more subtle 
point is that the function of memory cells also de- 
creases with age. 
The accumulation of memory cells largely ac- 
counts for the age-related loss of Con A respon- 
IL-3. 
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Figure 1. Age-related increase in the proportion of Pgp- 
Ih' cells in spleen, lymph node, and blood. Separate anal- 
yses were performed for CD4' and for CD8' cells. For 
the spleen cells, n values (shown within the bars) refer to 
the number of individual mice tested. n = 5 for each bar 
in the blood and lymph node experiments. The error bars 
refer to 95% confidence intervals on the mean. Reprinted 
with permission from Lerner et aLz 
siveness, of IL-2 and IL-3 production, and of IL-2- 
responsive cells. We have some hints as to the mo- 
lecular basis. We studied two aspects of early signal 
transduction. Each panel of Figure 5 is a histogram 
of 10,000 young or 10,000 old unstimulated T cells 
from our calcium assay. The horizontal axis is pro- 
portional to the calcium concentration in individual 
cells. Time 0 shows that the calcium level is almost 
identical in young and old cells prior to stimulation. 
When cells are stimulated with Con A, however, 
after 5 minutes (the peak of the calcium response) 
70-75% of the T cells from young mice have gen- 
erated a calcium signal. In old mice there is also a 
calcium response, and the kinetics are the same as 
those of young mice, but the number of cells that 
generate a calcium signal has declined by a factor 
of two. Thus, there is an age-related loss in the frac- 
tion of cells that can generate a calcium signal. 
We have also looked at other early signal trans- 
duction molecules, for example protein kinases. In 
Figure 6 we have taken T cells, stimulated them for 
2, 5, or 10 minutes with anti-CD3 and then, by 
western blot analysis method, estimated the amount 
of tyrosine-specific phosphorylation of three sub- 
strates. The top panel shows a substrate with a mo- 
lecular weight of 120 kDa, the middle panel 80, and 
the lower panel 40 kDa. These three species are 
stimulated by Con A or anti-CD3. Each point rep- 
resents an average of 9-11 young and 9-11 old 
mice. For all three substrates, and for all three time 
points, the young mice generate more tyrosine-spe- 
cific protein kinase than that generated by old mice. 
So calcium signals and kinase specific signals de- 
cline with advancing age. 
Can we explain these signal changes on the ba- 
Figure 2. Preferential activation of naive T cells by Con 
A. pIL-2 (left panel) and pIL-3 values (right panel) rep- 
resent means (+SEM) of three experiments, each involv- 
ing splenocyte samples from one young (3-6 month) and 
one old ( I  9-20 month) female mouse and are expressed 
per 10' CD4' cells. The frequencies of pIL-2 and pIL-3 
were higher among CD44I0 cells (p < 0.01 for pIL-2 cells 
and p < 0.001) compared to unsorted controls (ANOVA 
followed by planned comparisons of cells subsets, age 
groups combined, using log-transformed data). Data for 
unsorted cells from young and old mice are provided for 
comparison to other cell subsets. Inserts show precursor 
frequencies of the CD45RB'" cells on an expanded scale. 
Reprinted with permission from Flurkey et al.' 
sis of the cellular changes, related to a shift to pro- 
duce memory lymphocytes? Does this account for 
early changes in the inability of cells to respond to 
stimulating agents? The answer is "yes" for calci- 
um and "yes" for the tyrosine-specific kinases. Phi- 
losophe's work2 shows the calcium data (Figure 7). 
The vertical axis is CD44+ or P-GP-I+, everything 
Figure 3. Preferential activation of naive T cells by SEB. 
pIL-2 (left panel) and pIL-3 values (right panel) represent 
means (+SEM) of three experiments, each involving 
splenocyte samples from one young (3-6 month) and one 
old (19-20 month) female mouse, expressed per 10' 
CD4' cells. The frequencies of pIL-2 and pIL-3 were 
enhanced in the CD44lo subset (p < 0.05) and diminished 
in the CD45RBIo subset (p < 0.001) compared to controls 
(ANOVA, planned comparisons: log-transformed data). 
Reprinted with permission from Flurkey et a1.I 
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Figure 4. Responder cell frequencies among splenic T 
cells sorted for Pgp-l density. Splenic sIg- cells were 
stained for Pgp-I, gated by forward- and site-scatter sig- 
nals, and sorted into Pgp-Ihi (upper quartile) and Pgp-1’” 
(lower quartile) populations. Sorted cells, together with a 
mock-sorted (open window) control population, were 
then tested by LD to estimate their frequency of Con 
A-induced responsive helper (pHTL), proliferator (pPTL) 
and cytoxic (pCTL) cells. Values shown are means f 
SEM for n = 9 experiments, each involving one young 
and one old mouse. Reprinted with permission from Ler- 
ner et al.’ 
above the dotted line is a memory cell, and every- 
thing below is a virgin cell. Unstimulated memory 
and virgin cells have the same calcium levels. Once 
stimulated with Con A or antibody to the CD3 com- 
plex, or even ionomycin, which bypasses the signal- 
transducing mechanisms completely, cells show the 
same pattern of response. Memory cells are quite 
resistant to the increase in calcium signals; virgin 
cells generate quite a nice calcium signal to Con A, 
anti-CD3, or ionomycin. The ionomycin response, 
in particular, suggests that there might be an intrin- 
sic resistance of memory cells to increases in their 
calcium level. This might be mediated through a 
pump that pumps calcium out of the cell and back 
into the medium. 
We have also used a cell-sorter to isolate cells 
that generate a calcium signal in both young and 
old mice. Figure 8 represents cells that do (CaR) or 
do not (CaNR) generate a calcium signal after they 
were exposed to ionomycin. Most of the CaR cells 
could proliferate, make IL-2, and turn into cytotoxic 
cells. Cells that do not generate a calcium signal are 
also functionally incompetent. That is true for 
young and old mice. If the calcium signal is gen- 
erated, i t  largely accounts for the ability of cells to 
proliferate in response to IL-2, make IL-2 or IL-3, 
or generate cytotoxic clones. In the case of calcium, 
the cellular changes probably can explain the bio- 
chemical changes. This is also true for changes in 
tyrosine-specific protein kinases. Figure 9 shows the 
effect of age on the phosphorylation of three anti- 
CD3-inducible phosphotyrosine-containing proteins 
using results from western blots. Unfractionated 
CD4+ T cells do better than the memory cell subsets 
of the CD4+ T cells. When memory cells have been 
isolated, you have cells that do not generate strong 
phosphorylation of any of these responsive proteins. 
The age-associated increase in memory cells 
also accounts for the shift toward a decline in ty- 
rosine-specific kinase phosphorylation of these 
three substrates. The major weakness in these data 
is that we do not yet know the function of these 
substrates or kinases. 
Finally, I would like to mention two new inves- 
tigations. First, we are subdividing the virgin sub- 
sets or the memory subsets even further in func- 
tional ways. Jacek Witkowski has taken advantage 
of a property of the dye called rhodamine 123 
(R123).3 R123 stains young and old T cells equally 
well, but if the stained cells sit for 30 minutes the 
old T cells pump the rhodamine out; the young T 
cells do not. We believe this phenomenon is due to 
P-glycoprotein, an ATP-dependent plasma mem- 
brane pump that mediates multiple-drug resistance. 
This pump is present in normal cells, including nor- 
mal lymphocytes of old mice. The reason it is worth 
presenting in this context is that it subdivides the 
virgin and memory T cell pools. Figure 10 shows 
memory and naive cells from mice of different 
ages; the memory cells (CD44hl) are in the upper 
half and the virgin cells (CD44’”) are shown in 
the lower half. The R 123-high population includes 
both memory and virgin cells. Even in the young 
mice, there is a subset of memory cells that can 
pump out rhodamine because they have consider- 
able P-glycoprotein. With aging, there are more 
memory cells; however, in this context, the critical 
issue is that in old mice, more than 56% of memory 
cells have a lot of P-glycoprotein and pump the rho- 
damine. 
We wondered whether this change has any func- 
tional implication. Is there anything memory cells 
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Figure 5. Flow cytometric analysis of T-cell activation. One pair of analyses is shown, representative of eight young 
and seven old mice tested. Each histogram presents an analysis of 10,000 cells; the vertical axis gives the number of T 
cells with the fluorescence ratio (E405E485, a measure of Ca,) corresponding to each channel on the horizontal axis. 
Channels on the right correspond to increasing levels of Ca,. Each set of  six panels (young T cells at the top: old T 
cells at the bottom) depicts cells sampled at I-minute intervals after addition of 10 p,g/mL Con A to a suspension of 2 
X lo6 T cells in 1 mL of Krebs Ringer Phosphate at 37°C. Reprinted with permission from Miller et a1.6 
cannot do in old mice that could be attributed to 
this shift? To investigate this, we looked at IL-4 
production in a novel assay. In short-term assays 
the reported results are controversial, with some 
showing increases in IL-4 with advancing age, 
while others have reported decreases in production. 
We used different assay conditions to stimulate T 
cells with anti-CD3 for 2 days, then adding IL-2 to 
the cultures, since IL-2 has been shown to be im- 
portant in IL-4 production. Figure 1 I shows that 
IL-4 production 3, 6, or 9 days after the addition of 
IL-2 was higher in young mice than in old mice. 
Thus, under this assay condition, aging seems to 
lead to a decline in the response to IL-2 as measured 
by IL-4 production. We found, as many others have 
found previously, that the memory cell population 
is responsible for this. Memory cells from old mice 
are plentiful but they are functionally deficient in 
terms of IL-2-driven IL-4 production. So we asked 
what if we looked at this after subdividing the mem- 
ory cells using the rhodamine exclusion assay. We 
found that the rhodamine-high population, the sub- 
set predominant in young mice, makes essentially 
all the IL-4.3 We started with CD4' memory cells 
so we were not worried about contributions from 
CD8' or virgin cells-just the memory CD4' cells. 
Of that subset, it is only the rhodamine-high pop- 
ulation that can make IL-4. The rhodamine-low 
population, which increases with age, is unable to 
make IL-4. 
Looking at other antigens, other lymphokines, 
and other stimuli establishes the principle that the 
rhodamine dichotomy, which is age sensitive, has 
at least one functional implication and possibly oth- 
ers we now need to study. Even the rhodamine-high 
population in old mice does not adequately make 
1L-4. It is better than the rhodamine-low population, 
but there is a defect in IL-4 production that cannot 
simply be explained by rhodamine sensitivity. 
The question remains whether all of these cel- 
lular or molecular changes have implications for 
health. We have done a longitudinal study in mice, 
and we are about halfway through it. I will present 
the initial results. We tested mice at 6 months of 
age for several age-sensitive aspects of immune 
function to determine whether mice that looked im- 
munologically old at 6 months of age were more 
susceptible to cancer. We used a genetically hetero- 
geneous population rather than inbred mice, be- 
cause inbred animals tend to die of the same pa- 
thology. A four-way cross-breeding scheme insured 
that we had a population in which no two mice were 
genetically identical. We then measured immune 
function and then let these mice die of natural caus- 
es. Five of the group of 40 died before their 18- 
month birthday; all died of some form of cancer. 
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Figure 6. Age-related decline in tyrosine phosphoryla- 
tion of three substrates in response to aCD3 antibody. 
Values are means ? SEM from 7-10 experiments per 
time point for p120 and p80, and 4-6 experiments per 
time point for p40. Reprinted with permission from Shi 
and Miller.' 
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Figure 7. Differential responses of Pgp- 1 + and Pgp- 1 - T 
cells to activating agents. The distribution of calcium con- 
centrations was measured in T cells (from a young 
mouse) prior to stimulation, or after exposure to Con A 
(10 kg/mL), aCD3 antibody (1:10,000 dilution of ascites; 
cross-linked with 5 kg/mL rabbit anti-mouse Ig), or io- 
nomycin (20 ng/mL). T cells were labeled with indo-I 
and with fluorescein-conjugated anti-Pgp- 1 antibody, and 
samples of 20,000 cells were examined by flow cytome- 
try either 3 minutes (aCD3, ionomycin) or 4 minutes 
(Con A) after activation. The vertical axis shows log 
green fluorescence as a measure of Pgp-1 staining; the 
horizontal dashed line indicates the threshold used to dis- 
tinguish Pgp- 1 + from Pgp- 1 ~ T cells. The horizontal axis 
represents the ratio of indo-1 emission at 405 nm divided 
by emission at 480, as a measure of intracellular free 
calcium ion concentration. Ninety percent of the unstim- 
ulated cells have [Ca], values less than that indicated by 
the vertical dashed line (calcium threshold). The calcium 
scale for the ionomycin treatment differs from that of the 
other three panels, since even the least-responsive cells 
increase [Ca], to some extent when treated with iono- 
mycin. Reprinted with permission from Philosophe and 
Miller.2 
Figure 8. LD analyses of cells from young donors sorted 
into calcium responder (CaR) and calcium non-responder 
(CaNR) pools after stimulation with Con A. Each line con- 
nects points' representing frequency determinations from 
a single experiment. Results are shown for assays of Con 
A-responsive proliferating (pPTL), IL-2-secreting 
(pHTL), and cytoxic (pCTL) T cells. Reprinted with per- 
mission from Philosophe and Miller.* 









Figure 10. RI 23 staining distributions within naive 
(CD44'") and memory (CD44h1) T cell subsets in young, 
middle-aged, and old mice. T cells stained with R123, 
anti-CD4 (top panels) or anti-CD8 (bottom panels), and 
anti-CD44. The CD4 (or CD8) signal was used to exclude 
CD4- or CD8- from the analysis. The horizontal line 
shows the threshold used to discriminate CD44h' from 
CD44'" cells, and the vertical line shows the criterion used 
for RI 23 discrimination. Reprinted with permission from 
Witkowski and Miller.Io 
mune systems. The CD44+ memory population of 
the CD4' cells was high at 6 months in those ani- 
mals destined to die young. The CD44+ population 
of the CD8' cells, memory killer cells, was also 
statistically significantly higher in these animals. 
We also looked at virgin cells. Our prediction 
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Figure 9. Effect of anti-CD3 on levels of tyrosine-spe- 
cific protein phosphorylation in unfractionated CD4 and 
CD4 memory T cells from old and young mice. Values 
are mean ? SEM from four experiments. US, unstimu- 
lated. Reprinted with permission from Shi and Miller.9 
There were four different forms in the population, 
but all the deaths were from some aspect of neo- 
plastic disease. There was a statistically significant 
trend for the mice that died early to have aged im- 
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Figure 11. IL-4 secretion by unfractionated, naive, and 
memory CD4 T cells from young and old mice in 9-day 
cultures. Each 0.2-mL well contains 104 T cells of the 
indicated subset from young or old donors, as well as 104 
young resident peritoneal cells (RPC) as accessory cells. 
Cells were preactivated by incubation with anti-CD3 an- 
tibody for 2 days and then further incubated with IL-2 
plus. anti-CD3 for the indicated expansion time. The level 
of IL-4 produced during each indicated culture interval 
is plotted as mean -t SEM for n = 7 independent exper- 
iments. Reprinted with permission from Li and Miller.11 
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was that they would be lower in mice destined to 
die because virgin cells decline with age. That is 
what we found. The five mice that died at 18 
months had, at 6 months of age, fewer virgin cells 
than their counterparts that were going to live be- 
yond their 18-month b i r t h d a ~ . ~  
We also found that functional indices of immune 
response correlated with the development of neo- 
plastic diseases. For example, of the fraction of 
blood cells that could respond to Con A and IL-2 
by proliferating, those that had low levels of Con 
A- and IL-2-stimulated proliferation were also in 
the mice destined to die of cancer before their 18- 
month birthday. We hope that what we are measur- 
ing here is an association between T-cell status and 
tumor development as indicators of underlying ag- 
ing rate. We would have also been happy if instead 
we had proven that aging of the immune system 
predisposes an individual to tumor development. It 
is an open and hotly contested issue as to whether 
the immune decline with age does or does not leave 
elderly people more susceptible to cancer. One may 
ask whether animals with an aging immune system 
get cancer more quickly than younger animals. It is 
possible that an early phase of neoplastic transfor- 
mation in the 6-month-old mice led secondarily to 
a change in their immune function. We picked up 
that change in immune function, and a year later 
animals with impaired immune functions died. 
However, four forms of cancer were found in the 
population, and these are the type of tumors that are 
generally not detectable a year before death, but we 
still have not ruled out this possibility. 
What I have tried to convey is that there is a 
meaningful way to talk about immune deficiency i n  
the elderly. Changes in the cellular composition of 
the immune system are detectable by memory cell 
markers, virgin cell markers, and the newer P-gly- 
coprotein marker. These age-associated changes ac- 
count for some, but not all, of the functional 
changes, some lymphokine responses, and some 
lymphokine-production responses. In our prelimi- 
nary longitudinal study, these markers allowed us 
to identify, early in life, mice that are more prone 
to cancer or early death. These correlations could 
represent some link to an underlying aging rate or 
could represent an ability of the healthy immune 
system to protect animals from cancer. 
Discussion 
Weksler: 
Despite Dr. Miller’s apologia at the beginning of his 
talk, I feel that all his data are compatible with the 
state of dysregulation of the immune system. With 
regard to whether autoantibodies are good or bad, 
clearly that is a very difficult subject. One could 
say that they are associated with bad things, but that 
might just be coincidence and this has always been 
the question with autoimmune disease. Just because 
two things are linked does not mean that they are 
causally related. However, I think we are increas- 
ingly recognizing that certain autoantibodies can, in 
fact, transmit disease, like myasthenia gravis. So in 
certain cases we are making a stronger argument 
that the association is not just an association. Cer- 
tainly autoimmune “disease”-if you want to con- 
sider it as s u c h - o f  aging is a good deal more subtle 
than the autoimmune diseases we currently recog- 
nize. It would be increasingly difficult to prove cau- 
sality. I have tried to show one type of autoanti- 
body, auto-anti-idiotypic antibody is associated with 
a poor response to normal antigens. 
With regard to Dr. Miller’s provocative studies 
in  neoplastic disease, the one question I have is that 
since four out of five malignancies were lymphoid, 
do you think the shifts you saw were due to a neo- 
plastic clone? Have you been able to phenotype the 
neoplasms, and do they fall within the clonal ex- 
pansion or not? 
Miller: 
As to your specific question, lymphoma kills mice 
very quickly so that in cross-sectional pathology 
studies it is badly underestimated by factors of 
around three- to fourfold. In general, it is not rec- 
ognizable to a pathologist, even working with so- 
phisticated tools, a year prior to the demise of the 
mouse. That is the main reason we think it unlikely 
that the immune deficiency we saw was secondary 
to a malignant state. There was no  statistically sig- 
nificant effect or detectable effect of CD3+, CD4+, 
or CD8+ numbers, so if these are clones, they are 
funny clones. They would have to be equally dis- 
tributed among the CD3+, CD4+, CD8+, and B cell 
lineage. That I think argues against the idea that 
there was a clonal expansion of the malignant cell: 
it would have shown up as a change in CD3+, 
CD4+, CD8+, or B cell numbers. 
Weksler: 
But you would agree that the neoplasm that killed 




Did you see a clonal change? 
Miller: 
We did not look at the T cell receptor repertoire at 
6 months of age. There was no change at 6 months 
in the mice that were destined to get T cell tumors 
in CD4+ and CD8+ cells. The only changes we saw 
were those that were age sensitive in the memory 
virgin cell. 
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As to your more general philosophical point, I 
am sensitive about the use of words to describe the 
age-associated changes. The reason I am sensitive 
is that I have seen my grants, and grants of many 
other people, rejected by reviewers who argue that 
immune function aging is not a matter of deficiency, 
so why bother to study deficiency when i t  is due to 
autoantibodies? I think it  is important in conveyi.ig 
to a casually educated public that the situation is 
more complex, and that it cannot be expressed in a 
single word. 
Keusch: 
To get back to the question of premalignancy: I 
wonder about your data with P-glycoproteins, since 
many glycoproteins and glycolipids are differenti- 
ation markers altered in the expression of neoplastic 
cells. Could it be a marker of ultradifferentiation, 
or a premalignant state? 
Miller: 
P-glycoprotein-positive cells increase with age in 
the mice we have studied. This could be an advan- 
tage to a cell and it may well be that the P-glyco- 
protein-high subsets of these cells are the ones des- 
tined to become malignant. We have no evidence 
for or against that idea. It is known that P-glyco- 
protein is high in tumor cells prior to exposure to 
antitumor drugs, so i t  is typically present at higher 
levels in malignant cells in ways that cannot be ex- 
plained by xenotoxic selection. In all the old mice 
we looked at, about 70% of the T cells are high in 
P-glycoprotein, regardless of whether the mice later 
died of T cell malignancies. 
Chandra: 
I am confused: first memory cells appear, then the 
malignancies appear, and then the malignancy con- 
tributes to the memory cells? 
Miller: 
Let me clarify that. There is a memory cell shift in 
some mice by 6 months of age; a year later these 
mice are found to have cancer. So we hypothesize 
that the mice who develop memory cells rather pre- 
maturely compared to their siblings are the ones 
who are predisposed to the developing cancer. 
Meydani: 
In the last few slides, were all the individual ani- 
mals the ones that would later die? If not, how do 
you explain their survival? 
Miller: 
To develop a cancer you need to have more than a 
poor immune system-perhaps a genetic predispo- 
sition to that cancer or an encounter with a carcin- 
ogen. Cancer is a complicated phenomenon, and 
what we are trying to argue is that immune defi- 
ciency is not the only cause, but that it is one of 
the key factors that predispose to tumorigenesis. 
When all the mice have died i t  will be interesting 
to see whether those that had poor immunity at 6 
months, I I months, or 18 months, subsequently 
died of malignancies or a particular kind of malig- 
nancy. 
Kelley: 
Your data on the ability of memory cells to pump 
rhodamine out of the old mice was particularly in- 
teresting to me. You mentioned that you let it sit 
around for 30 minutes or an hour? Since T cells are 
now known to die apoptotically, is there any dif- 
ference between the virgin cells and memory cells 
in terms of apoptosis in vitro? 
Miller: 
I don’t know of any data on  susceptibility of T cells 
from young or old mice to apoptosis. Rhodamine 
and calcium extrusion in these normal healthy cells 
is biochemically unrelated to apoptosis. 
Kelley: 
That is why I think it’s a relevant question, but you 
have not looked at it? 
Miller: 
No we have not. 
Goodwin: 
Your data on malignancy, was it  four or five or three 
or four mice that died of lymphoid malignancy? 
That is interesting. There is a lot of literature on 
immunosuppression in humans and subsequent ma- 
lignancy and several explanations for these results 
come to mind. In humans, lymphoid malignancy is 
the tumor type that increases. If you just immuno- 
suppress for something like rheumatoid arthritis, it 
is very difficult to show the increased malignancy. 
But in aging most of the increases could be consid- 
ered lymphoid-type malignancies. Is immunosup- 
pression in your model leading to the concept of 
immune surveillance? Or is the immunodysregula- 
tion that you are showing in these younger animals 
leading to immune-related tumors? 
Miller: 
The hypothesis I favor is that the premature decline 
in immunity and the premature development of dis- 
ease are linked because they are both caused by 
changes in the rate of aging. We intend to study 
these mice from many aspects of immune and non- 
immune aging. We have collaborators who will be 
measuring fibroblast growth rate, IL-6 production, 
collagen cross-linking, retroviral production, and 
skeletal muscle function. If many or all of these 
parameters decline in parallel in those mice that die 
young, that will make a strong case for their being 
linked together, not by cause and effect mechanisms 
but because they are associated with relatively pre- 
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mature aging. It would be hard to argue that loss of 
muscle strength is what leads to lymphoma. If, how- 
ever, we find that the only good predictors of neo- 
plasm are the immune markers and that the retro- 
virus or muscle strength and collagen had no 
correlation, then the hypothesis you just suggested, 
that immune deficiency specifically predisposes an 
individual to immune neoplasms, will be supported. 
Some of our animals are now dying of other dis- 
eases, including amyloid, aortic aneurysms, and ne- 
phritis. The mice are genetically heterogeneous, and 
fortunately they are dying of many different things, 
which we can now examine in this context. 
Keusch: 
It has recently been demonstrated that some of the 
differentiation markers related to glycolipids are 
signals for apoptosis. If the P-glycoprotein changes, 
or if there is some alteration in terminal differenti- 
ation, that might pertain to other glycosylated sur- 
face markers that may be signals for apoptosis and 
loss of populations. 
Miller: 
We are not at all convinced that the increase with 
age in P-glycoprotein function accounts for the im- 
portant properties of these cells. We think it is more 
likely to be a marker of some other differentiation 
state that was not well tracked before the rhoda- 
mine-extrusion test. Cells high in P-glycoprotein 
may differ in interesting ways. IL-4 production in 
the presence of IL-2 is the first for which we have 
good data, but there may well be other sensitivities, 
which predispose them to autoreactivity. We need 
to look at all of this. 
Weindruch: 
I think your hybrid mice are an excellent model. I 
have always been surprised at the amount of het- 
erogeneity that I see in inbred strains, not only with 
immunologic assays but also with very basic things 
like metabolism efficiency. Some mice eat a lot of 
food and do not weigh much; heavier mice eat less 
food. Have you done statistical analyses in your hy- 
brid mice for the degree of variation in markers of 
immune senescence you measured, and have you 
compared that to the old “standard” brand of mice? 
Miller: 
Once we have a larger data set on these hybrid mice 
we will be asking those questions. Drs. Jay Phelan 
and Steve Austard have asked the more general 
question: do inbred mice have a narrower or wider 
variance compared to genetically heterogeneous an- 
imals? Based on a literature survey, they have 
shown that inbreeding often does not lead to a nar- 
rowing of variance, but rather to an expansion in 
phenotypic variance; the control mechanisms that 
we heterozygotes maintain for homeostatic control 
have been eliminated in inbred animals. Therefore, 
we need to test that specific question. My expecta- 
tion is there will not be a great increase in variance 
in the hybrid mice. 
Chandra: 
What proportion of the old mice die of diseases oth- 
er than tumors, and do you have any preliminary 
information on lymphocyte subset changes in those? 
Miller: 
The 48th percentile mice died earlier this week, so 
as yet we have no information on the genetic back- 
ground of the last half of the aging curve. Lympho- 
mas continue to predominate. More than half of the 
mice die with some form of malignancy, but we 
also have seen animals that have died of heman- 
giosarcoma, granulocytic leukemia, aortic or vas- 
cular aneurysm, and nephritis. We are still waiting 
to see what will happen to the remaining 50% of 
the population. 
Chandra: 




If we feed a normal-calorie diet to our strains of F, 
and C57BW6, we see about 80% dying with 
cancer; typically lymphoma and hepatoma. If we 
feed low-calorie diets, cancer incidence is reduced 
3040%. 
Bendich: 
Is there a virus that causes tumors in  mice? 
Miller: 
If mice are homozygous for a virus that causes thy- 
mic lymphoma, and also have genes that make them 
susceptible, and you make an F, hybrid, the inci- 
dence of the AKR type tumor goes down. The AKR 
genotype is randomly distributed across these ani- 
mals so that the animal has 25% of the AKR ge- 
notype. 
Bendich: 
Do you look for the virus? 
Miller: 
We looked for the pathology caused by the virus, 
and we did not see it in these animals. There are 
also other tumor viruses, segregating in these cross- 
es, but the heterozygosity tends to protect them 
from diseases typically present in inbreds. 
Weksler: 
In William Adler’s report from The Baltimore Lon- 
gitudinal Study on Aging, there was an unexplained 
decrease in lymphocyte counts in the 3 years prior 
to a person’s demise from any cause. 
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Miller: 
A 10-15% decline in total lymphocyte number oc- 
curs in the year prior to death in healthy humans, 
regardless of the age of death. 
Chandra: 
This indication grows stronger if there is also cu- 
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